Treatments of last resort: informed consent and the diffusion of new technology

Mercer Law Rev. 1991 Spring;42(3):1007-50.
No abstract available

MeSH terms

  • Acquired Immunodeficiency Syndrome
  • Altruism
  • Beneficence
  • Biomedical Technology*
  • Coercion
  • Congenital, Hereditary, and Neonatal Diseases and Abnormalities
  • Cost-Benefit Analysis
  • Decision Making*
  • Disclosure*
  • Drugs, Investigational
  • Equipment and Supplies
  • Evaluation Studies as Topic
  • Fetal Diseases / therapy
  • Freedom
  • General Surgery
  • Government Regulation
  • Heart
  • Heart Diseases
  • Human Experimentation
  • Humans
  • Infant, Newborn
  • Informed Consent*
  • Jurisprudence
  • Kidney Diseases
  • Malpractice
  • Organ Transplantation
  • Parental Consent
  • Paternalism
  • Patient Care
  • Patient Participation
  • Personal Autonomy
  • Physicians*
  • Prenatal Diagnosis
  • Reference Standards
  • Research*
  • Risk Assessment*
  • Risk*
  • Social Control, Formal
  • Technology Assessment, Biomedical
  • Terminally Ill
  • Therapeutic Human Experimentation*
  • Third-Party Consent
  • United States
  • United States Food and Drug Administration
  • Withholding Treatment
  • Wrongful Life

Substances

  • Drugs, Investigational